|
TeraView Limited, is the world’s
first and leading innovator of 3-D imaging and spectroscopic
systems which exploit the properties of terahertz to characterise a wide range of materials.
Our patented terahertz technology creates spectroscopic
information and 3D images with unique spectroscopic
signatures not found at other wavelengths. It resolves
many of the questions left unanswered by complementary
techniques, such as optical imaging, Raman and infrared.
Terahertz technology also produces faster results
than X-ray and enables non-destructive, internal,
chemical analysis of tablets, capsules and other
dosage forms.
TeraView’s
vision is to make terahertz technology affordable,
accessible, and ubiquitous in everyday
life.
TeraView
was spun-out of Toshiba Research Europe in April
2001 by its co-founders, Sir Michael Pepper
(CSO) and Dr Don Arnone (CEO), to exploit the intellectual
property and expertise developed in sourcing and
detecting terahertz (1 THz= 33.3cm-1) radiation,
using innovative semiconductor technologies. Leading
industry
proponents of the technology sit on our Advisory
Board, and TeraView maintains close links with the
Cavendish Laboratory at the University of Cambridge,
where modern terahertz technology was pioneered in
conjunction with the team at TeraView, and where
Professor Pepper, has held the position of Professor
of Physics since 1987.
Uniquely, the Company has
a wealth of experience in both the technology to
generate, detect and manipulate terahertz light,
as well as an extraordinary breadth and depth of
knowledge in applications of the technology in
different markets to solve real world problems for
our customers.
Both of these attributes are represented in our
product offering to customers, as well as an impressive
intellectual
property portfolio that builds considerable value
for the Company. The result is our proprietary
TPI™ platform that can be configured to meet a variety
of end-user needs.
TeraView
seeks to exploit its TPI™ platform by working closely
with select customers, and strongly supporting
our products and their implementation with these
customers. The Company is also dedicated to providing
end-users with the benefit of both our technology
as well as expertise in the manipulation of terahertz
light. To this end, we seek to provide complete solutions
to our customers’ business issues, using the
considerable experience of our engineering and applications
support teams, who have considerable knowledge of
the optimization of Terahertz to address the issues
faced by our customers.
TeraView is currently working closely with major
pharmaceutical customers to support implementation
of our products in pharmaceutical drug formulation,
product development and manufacturing. The Company
also actively works with customers in the analytical
instrumentation and defense sectors, including
close support of government laboratories active
in homeland
security and other defense-related applications.
Where required, the Company is also dedicated to
developing alliances with commercial partners
targeted at specific market applications for
sales to and
support of end-users. The Company currently has
alliances with global leaders in the analytical
instrumentation
market, security and defense, and medical markets
to support work with customers in these areas.
The Company currently operates in Europe,
as well as having an office and representatives in
the US and North America. TeraView is also
actively engaged with customers in Japan.
|
